Genomenon, Inc vs MiraDx

Genomenon, Inc logo

Genomenon, Inc

Genomic intelligence for clinical diagnostics and precision medicine development

151 employees · est. 2014 · Ann Arbor, United States

VS
MiraDx logo

MiraDx

Tailoring cancer treatment based on your patient’s unique response and toxicity profile

28 employees · est. 2010 · Los Angeles, United States

MiraDx is the older company (2014 vs 2010); Genomenon, Inc is the larger of the two.

Side-by-Side Comparison

Genomenon, Inc MiraDx
Founded
2014 2010 older
Headquarters
Ann Arbor, United States Los Angeles, United States
Employees
151 larger 28
Industry
Developer Tools, Enterprise Software Biotechnology, Health Care
Funding Stage
Venture round Series A
Total Funding
$38.23M $4.00M
Funding Rounds
9 1
Services
Not tracked yet Personalized Cancer Treatment, Biomarker Discovery and Application, Toxicity Profile Assessment, Genetic Testing Services
Target Customers
Not tracked yet Oncologists, Pathologists, Cancer Patients, Medical Researchers
Taxonomy
GenomicsPharmaceuticalsClinical DiagnosticsSoftware ToolsGenetic DiagnosticsBioinformatics +6 BiomarkersMicroRNAGenetic ResearchPersonalized Cancer TreatmentRadiationChemotherapy +7
Website
genomenon.com miradx.com
Genomenon, Inc logo

About Genomenon, Inc

Genomenon, Inc is a leading genomic intelligence company founded in 2014, with the mission to enhance patients’ lives by identifying the genomic drivers of genetic disease and cancer. Their slogan, "Genomic intelligence for clinical diagnostics and precision medicine development," encapsulates their...

MiraDx logo

About MiraDx

MiraDX, Inc. is a biotechnology company at the forefront of personalized cancer treatment, utilizing unique microRNA-based biomarkers. Founded in 2010 by Dr. Joanne Weidhaas and Dr. Frank Slack, the company is headquartered in the United States. MiraDX's mission is to leverage proprietary biomarker...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Genomenon, Inc and MiraDx for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Genomenon, Inc or MiraDx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Genomenon, Inc was founded in 2014, based in Ann Arbor, United States, with 151 employees. Genomenon, Inc is a leading genomic intelligence company founded in 2014, with the mission to enhance patients’ lives by identifying the genomic drivers of genetic disease and cancer. Their slogan, "G. MiraDx was founded in 2010, based in Los Angeles, United States, with 28 employees. MiraDX, Inc. is a biotechnology company at the forefront of personalized cancer treatment, utilizing unique microRNA-based biomarkers. Founded in 2010 by Dr.
Genomenon, Inc has raised $38.23M and MiraDx $4.00M. Latest stage: Genomenon, Inc Venture round, MiraDx Series A.
Both list genomics, oncology and precision medicine among their focus areas.

Compare Genomenon, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genomenon, Inc on 11 Sep 2024, and MiraDx on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes